153 related articles for article (PubMed ID: 31039471)
1. Design, synthesis and molecular docking of new N-4-piperazinyl ciprofloxacin-triazole hybrids with potential antimicrobial activity.
Mohammed HHH; Abdelhafez EMN; Abbas SH; Moustafa GAI; Hauk G; Berger JM; Mitarai S; Arai M; Abd El-Baky RM; Abuo-Rahma GEA
Bioorg Chem; 2019 Jul; 88():102952. PubMed ID: 31039471
[TBL] [Abstract][Full Text] [Related]
2. Search for factors affecting antibacterial activity and toxicity of 1,2,4-triazole-ciprofloxacin hybrids.
Plech T; Kaproń B; Paneth A; Kosikowska U; Malm A; Strzelczyk A; Stączek P; Świątek Ł; Rajtar B; Polz-Dacewicz M
Eur J Med Chem; 2015 Jun; 97():94-103. PubMed ID: 25951434
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and molecular docking of new N4-piperazinyl ciprofloxacin hybrids as antimicrobial DNA gyrase inhibitors.
Mohammed HHH; Ali DME; Badr M; Habib AGK; Mahmoud AM; Farhan SM; Gany SSHAE; Mohamad SA; Hayallah AM; Abbas SH; Abuo-Rahma GEA
Mol Divers; 2023 Aug; 27(4):1751-1765. PubMed ID: 36152132
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and in vitro activity of 1,2,4-triazole-ciprofloxacin hybrids against drug-susceptible and drug-resistant bacteria.
Plech T; Wujec M; Kosikowska U; Malm A; Rajtar B; Polz-Dacewicz M
Eur J Med Chem; 2013 Feb; 60():128-34. PubMed ID: 23287058
[TBL] [Abstract][Full Text] [Related]
5. Design, Synthesis and Antibacterial Evaluation of 1-[(1R,2S)-2-Fluorocyclopropyl]ciprofloxacin-1,2,4-triazole-5(4H)-thione Hybrids.
Gao Y; Na LX; Xu Z; Zhang S; Wang AP; Lü K; Guo HY; Liu ML
Chem Biodivers; 2018 Oct; 15(10):e1800261. PubMed ID: 29987907
[TBL] [Abstract][Full Text] [Related]
6. Determination of the primary molecular target of 1,2,4-triazole-ciprofloxacin hybrids.
Plech T; Kaproń B; Paneth A; Kosikowska U; Malm A; Strzelczyk A; Stączek P; Świątek Ł; Rajtar B; Polz-Dacewicz M
Molecules; 2015 Apr; 20(4):6254-72. PubMed ID: 25859782
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological evaluation of ciprofloxacin tethered bis-1,2,3-triazole conjugates as potent antibacterial agents.
Kant R; Singh V; Nath G; Awasthi SK; Agarwal A
Eur J Med Chem; 2016 Nov; 124():218-228. PubMed ID: 27592391
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, molecular docking of new lipophilic acetamide derivatives affording potential anticancer and antimicrobial agents.
Ahmed HEA; Ihmaid SK; Omar AM; Shehata AM; Rateb HS; Zayed MF; Ahmed S; Elaasser MM
Bioorg Chem; 2018 Feb; 76():332-342. PubMed ID: 29227917
[TBL] [Abstract][Full Text] [Related]
9. Novel ciprofloxacin hybrids using biology oriented drug synthesis (BIODS) approach: Anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis, topoisomerase II inhibition, and antibacterial activity.
Kassab AE; Gedawy EM
Eur J Med Chem; 2018 Apr; 150():403-418. PubMed ID: 29547830
[TBL] [Abstract][Full Text] [Related]
10. New Caffeic Acid Derivatives as Antimicrobial Agents: Design, Synthesis, Evaluation and Docking.
Merlani M; Barbakadze V; Amiranashvili L; Gogilashvili L; Poroikov V; Petrou A; Geronikaki A; Ciric A; Glamoclija J; Sokovic M
Curr Top Med Chem; 2019; 19(4):292-304. PubMed ID: 30674263
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, antimycobacterial and antibacterial activity of ciprofloxacin derivatives containing a N-substituted benzyl moiety.
Wang S; Jia XD; Liu ML; Lu Y; Guo HY
Bioorg Med Chem Lett; 2012 Sep; 22(18):5971-5. PubMed ID: 22884110
[TBL] [Abstract][Full Text] [Related]
12. Molecular hybridization approach for phenothiazine incorporated 1,2,3-triazole hybrids as promising antimicrobial agents: Design, synthesis, molecular docking and in silico ADME studies.
Reddyrajula R; Dalimba U; Madan Kumar S
Eur J Med Chem; 2019 Apr; 168():263-282. PubMed ID: 30822714
[TBL] [Abstract][Full Text] [Related]
13. Oxazolone-1,2,3-Triazole Hybrids: Design, Synthesis and Antimicrobial Evaluation.
Lal K; Kumar L; Kumar A; Kumar A
Curr Top Med Chem; 2018; 18(17):1506-1513. PubMed ID: 30210002
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and antimicrobial evaluation of propylene-tethered ciprofloxacin-isatin hybrids.
Wang R; Yin X; Zhang Y; Yan W
Eur J Med Chem; 2018 Aug; 156():580-586. PubMed ID: 30025351
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antimycobacterial activity of 1-(β-d-Ribofuranosyl)-4-coumarinyloxymethyl- / -coumarinyl-1,2,3-triazole.
Srivastava S; Bimal D; Bohra K; Singh B; Ponnan P; Jain R; Varma-Basil M; Maity J; Thirumal M; Prasad AK
Eur J Med Chem; 2018 Apr; 150():268-281. PubMed ID: 29529504
[TBL] [Abstract][Full Text] [Related]
16. Novel berberine derivatives: Design, synthesis, antimicrobial effects, and molecular docking studies.
Yao L; Wu LL; Li Q; Hu QM; Zhang SY; Liu K; Jiang JQ
Chin J Nat Med; 2018 Oct; 16(10):774-781. PubMed ID: 30322611
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, antimicrobial activity and molecular modeling study of 3-(5-amino-(2H)-1,2,4-triazol-3-yl]-naphthyridinones as potential DNA-gyrase inhibitors.
Mohamed NG; Sheha MM; Hassan HY; Abdel-Hafez LJM; Omar FA
Bioorg Chem; 2018 Dec; 81():599-611. PubMed ID: 30248511
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antimicrobial potential of nitrofuran-triazole congeners.
Kamal A; Hussaini SM; Sucharitha ML; Poornachandra Y; Sultana F; Ganesh Kumar C
Org Biomol Chem; 2015 Sep; 13(36):9388-97. PubMed ID: 26238045
[TBL] [Abstract][Full Text] [Related]
19. Ciprofloxacin-1,2,3-triazole-isatin hybrids tethered via amide: Design, synthesis, and in vitro anti-mycobacterial activity evaluation.
Chen R; Zhang H; Ma T; Xue H; Miao Z; Chen L; Shi X
Bioorg Med Chem Lett; 2019 Sep; 29(18):2635-2637. PubMed ID: 31358466
[TBL] [Abstract][Full Text] [Related]
20. Probing linker design in citric acid-ciprofloxacin conjugates.
Milner SJ; Snelling AM; Kerr KG; Abd-El-Aziz A; Thomas GH; Hubbard RE; Routledge A; Duhme-Klair AK
Bioorg Med Chem; 2014 Aug; 22(16):4499-505. PubMed ID: 24794750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
